NCT06775964View on ClinicalTrials.gov

Stem Cell Therapy for Early Alzheimer's Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2027

Conditions
Cognitive Dysfunction
Interventions
BIOLOGICAL

adMSC

IV-infusion of autologous, adipose-derived, Mesenchymal Stem Cells (adMSCs), of approximately 2x10(8) adMSCs in 250mL saline.

Trial Locations (1)

77054

RECRUITING

The University of Texas Health Science Center at Houston (UTHealth), Houston

All Listed Sponsors
collaborator

Weston Brain Institute

OTHER

lead

Paul E Schulz

OTHER

NCT06775964 - Stem Cell Therapy for Early Alzheimer's Disease | Biotech Hunter | Biotech Hunter